Reactivation of cutaneous psoriasis during abatacept therapy for spondyloarthropathy

Joint Bone Spine. 2010 Dec;77(6):626-7. doi: 10.1016/j.jbspin.2010.09.015. Epub 2010 Oct 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abatacept
  • Adalimumab
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Female
  • Humans
  • Immunoconjugates / adverse effects*
  • Immunosuppressive Agents / adverse effects*
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / etiology
  • Psoriasis / immunology
  • Recurrence
  • Spondylitis, Ankylosing / complications
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / immunology
  • Treatment Outcome
  • Withholding Treatment

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoconjugates
  • Immunosuppressive Agents
  • Abatacept
  • Adalimumab